Brochure | March 25, 2024

Comprehensive ADC And Bioconjugation Services For Targeted Therapies

Factory Cleanroom GettyImages-1294339670

Discover a trusted CDMO partner with more than 15 years of industry-leading experience in conjugation and purpose-built manufacturing facilities. MilliporeSigma offers end-to-end services to bring your ADCs and bioconjugates into the clinic and to commercialization, employing a collaborative approach and ensuring a reliable supply chain for the development, manufacturing, and testing of bulk drug substance (BDS) and drug product (DP).

Equipped with the expertise to develop and manufacture your bioconjugate or ADC, MilliporeSigma has handled over 100 constructs, 1000 development batches, 60 INDs, and 240 GMP batches (including 25 for commercial use). Continue reading to learn more about these comprehensive ADC and bioconjugation solutions.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online